Gorik Ooms

@gorikooms.bsky.social

Human rights law; global health law

4/4 To protect the “unique genius” of the “race” of Ghent or Flanders or Belgium, shall we bar all other people from Ghent University? That is what Cofnas implies. He should never have been hired. No student should feel unwelcome or unwanted at Ghent University because of her/his/their “descent”.

3/4 “There must be some barriers set up between races in order for each one to express its own unique genius”, or so argues Cofnas. “Races” are “populations that are more or less distinguished from each other due to common descent”, or so argues Cofnas.

2/4 Should all opinions be allowed at universities? Imagine your daughter coming home from her first day at university, where a professor lectured her about why (in his humble opinion, of course) women should be barred from universities. Would you tolerate that? I would not.

1/4 Today, Ghent University suspended Nathan Cofnas. It was about time. There’s a fundamental difference between facts and opinions. Statements about facts are either true or false. Opinions are right or wrong, or somewhere in between. Opinions are always subjective, at least to some extent.

My Reflection from UN on HIV yesterday. Remarkable, paradoxical, dramatic. At turbulent moment, multilat'lism stuck on many fronts, Political Decl. is STRIKINGLY good on many issues. Fascinating political bedfellows. Signs of HIV crisis biting for com'ities. A thread on politics & policy: 🧵1/12

Bild

At Accra Reset event on the sidelines of WHA79, Ghana's health minister calls this a "historic moment" that "shifts us from passive recipients of aid to sovereign architects of our own health systems."

Today, MSF is going public with something we've been fighting behind closed doors for months: Gilead will not sell us their new HIV drug, lenacapavir. The sticking point isn't even price, they just refuse to sell. Open letter linked + explainer 🧵1/ www.doctorswithoutborders.org/latest/gilea...

Gilead refuses to sell groundbreaking HIV prevention drug to MSF

Blocking humanitarian organizations from accessing a medical breakthrough puts vulnerable people across the world in danger.

doctorswithoutborders.org

“In a partnership on equal footing, one side cannot decide to reduce a previously agreed contribution by 25% or 50%. A cooperation should be more reliable than a donor–recipient relationship,” says @gorikooms.bsky.social, health-policy researcher at ITM. www.nature.com/articles/d41...

The US and Europe have cut billions in health aid — can anyone fill the gap?

It's time to radically reimagine global health, leaders tell World Health Summit in Berlin.

nature.com

🇪🇺The 2025 EU #GHPF25 is taking place today, organised by the @ec.europa.eu in Brussels. 📝We will be present alongside many other civil society organisations to ask important questions regarding accountability and share key recommendations for the future of this strategy. See you there!

Bild